MonoRabᵀᴹ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit
MonoRab™ Anti-Pembrolizumab antibody (90G12) (GenScript, A01960-40) binds with Pembrolizumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Pembrolizumab, 1 μg/ml.
Anti-Pembrolizumab antibody dilution start from 1,000 ng/ml.
MonoRab™ Anti-Pembrolizumab antibody (90G12) (GenScript, A01960-40) blocks Pembrolizumab binding with Human PD-1 recombinant protein (Z03370, PD-1-Fc Chimera, Human).
Coating antigen: Pembrolizumab, 1 μg/ml.
PD-1-Fc-biotin final concentration: 20 ng/ml.
Anti-Pembrolizumab antibody dilution start from 10 μg/ml.
| Description | Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.
GenScript MonoRabᵀᴹ Anti-Pembrolizumab Antibody (90G12), mAb, Rabbit is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a rabbit immunized with Pembrolizumab. |
| Host Species | Rabbit |
| Conjugation | Unconjugated |
| Immunogen | Pembrolizumab |
| Purification | Protein A affinity column |
| Subclass | IgG |
| Clone ID | 90G12 |
| Concentration | 0.5 mg/ml, lyophilized with PBS, pH 7.4, containing 0.02% sodium azide. |
| Reconstitution | Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/ml. |
| Specificity | The product is specific for Pembrolizumab. This antibody blocks Pembrolizumab binding with human PD-1 recombinant protein (Z03370, PD 1 Fc Chimera, Human) in ELISAs. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01852-40, Anti-Pembrolizumab Antibody (129G11B9), mAb, Rabbit. |
| Storage | The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid freeze/thaw cycles. |
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
ELISA detection: 0.01-0.1 µg/ml ELISA blocking: 10-50 µg/ml Other applications: user-optimized |
MonoRab™ Anti-Pembrolizumab antibody (90G12) (GenScript, A01960-40) binds with Pembrolizumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Pembrolizumab, 1 μg/ml.
Anti-Pembrolizumab antibody dilution start from 1,000 ng/ml.
MonoRab™ Anti-Pembrolizumab antibody (90G12) (GenScript, A01960-40) blocks Pembrolizumab binding with Human PD-1 recombinant protein (Z03370, PD-1-Fc Chimera, Human).
Coating antigen: Pembrolizumab, 1 μg/ml.
PD-1-Fc-biotin final concentration: 20 ng/ml.
Anti-Pembrolizumab antibody dilution start from 10 μg/ml.
For more documents, please visit "Technical Support".
| Cat. No. A01960 | ||
|---|---|---|
Size |
Price |
|
| 40 µg | $198.00 | |
